Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
<p>Abstract</p> <p>Glycoprotein IIb/IIIa inhibitors represent a new promising class of antiplatelet medications. Their use in acute coronary syndromes and for patients undergoing percutaneous coronary intervention has been the subject of a number of large controlled trials using both the intravenous...
Sparad:
| Huvudupphov: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMC
2001-07-01
|
| Serie: | Current Controlled Trials in Cardiovascular Medicine |
| Ämnen: | |
| Länkar: | http://cvm.controlled-trials.com/content/2/4/171 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|